Ecstacy a/k/a Molly, Author DEA, Source https://www.dea.gov, (PD as work product of federal govt.)
“I am more convinced than ever that psychiatric medications, over the long term, cause net harm. I wish that weren’t the case, but the evidence just keeps mounting that these drugs, on the whole, worsen long-term outcomes…The inventor of frontal lobotomy…was awarded a Nobel Prize for inventing that surgery, which today we understand as a mutilation.”
-Award-winning science author and journalist, Robert Whitaker 
Recently, a number of drug trials have been conducted re-assessing the effectiveness of psychedelics for anxiety, depression, and post-traumatic stress disorder (PTSD).
While the results of these trials have been heralded as providing new treatment options for tenacious illnesses, there are serious dangers associated with psychedelics.
Psychedelics act on receptors in the brain for serotonin, a neurotransmitter that effects mood.
There is some thinking that psychedelics enhance the brain’s capacity to form and reorganize synaptic connections, especially following injury [3A]. But this hypothesis needs further research.
In the therapeutic setting, psychedelics cause a receptive, dream-like state during which memories are readily accessible [3B]. The theory is that this state opens the door to fresh ideas the therapist can introduce.
Unsupervised use is not recommended. Continue reading